| 6B30: reference: Discovery of orally efficacious RORgammat inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds., Shirai J, Tomata Y, Kono M, Ochida A, Fukase Y, Sato A, Masada S, Kawamoto T, Yonemori K, Koyama R, Nakagawa H, Nakayama M, Uga K, Shibata A, Koga K, Okui T, Shirasaki M, Skene R, Sang B, Hoffman I, Lane W, Fujitani Y, Yamasaki M, Yamamoto S, Bioorg Med Chem. 2017 Dec 9. pii: S0968-0896(17)31989-2. doi:, 10.1016/j.bmc.2017.12.006. PMID: 29262987 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).